https://pubmed.ncbi.nlm.nih.gov/41255102/
Treatment recommendations for patients with hepatitis C virus (HCV) genotype (GT) 3b infection and cirrhosis remain unclear. This multicentre randomized...
sofosbuvirvelpatasvirvoxilaprevirversusplus
https://www.aidsmap.com/news/nov-2012/simeprevir-safe-and-effective-interferonribavirin-hepatitis-c-patients-cirrhosis
The hepatitis C protease inhibitor simeprevir (formerly TMC435) was generally safe and well tolerated in people with advanced liver fibrosis or cirrhosis and...
simeprevirsafeeffectiveinterferonribavirin
https://www.aidsmap.com/news/jul-2013/abbvie-interferon-free-hepatitis-c-combo-works-well-reduced-ribavirin-dose
People taking hepatitis C treatment who reduced their dose of ribavirin due to side-effects nevertheless had a high likelihood of achieving sustained...
hepatitis cabbvieinterferonfreecombo
https://www.aidsmap.com/news/apr-2014/sofosbuvir-ribavirin-safe-and-effective-people-hepatitis-c-who-have-advanced-liver
Sofosbuvir plus ribavirin is a safe option that can lead to sustained response in people with advanced liver disease including those with decompensated...
sofosbuvirribavirinsafeeffectivepeople